Swift Biosciences Normalase Amplicon SARS-CoV-2 S Gene Panel

Swift Biosciences has released the Normalase Amplicon SARS-CoV-2 S Gene Panel (SNAP), a targeted gene panel that covers 100 percent of the SARS-CoV-2 S gene even with limited viral titers. The new panel eliminates the need to perform qPCR for library normalization for downstream sequencing, Swift said.